1 Study Coverage 1.1 Acute Kidney Injury Therapeutics Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) & (US$ Million) Introduction 1.2 Global Acute Kidney Injury Therapeutics Outlook 2017 VS 2022 VS 2028 1.2.1 Global Acute Kidney Injury Therapeutics Market Size for the Year 2017-2028 1.2.2 Global Acute Kidney Injury Therapeutics Market Size for the Year 2017-2028 1.3 Acute Kidney Injury Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Acute Kidney Injury Therapeutics in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Acute Kidney Injury Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Acute Kidney Injury Therapeutics Market Dynamics 1.4.1 Acute Kidney Injury Therapeutics Industry Trends 1.4.2 Acute Kidney Injury Therapeutics Market Drivers 1.4.3 Acute Kidney Injury Therapeutics Market Challenges 1.4.4 Acute Kidney Injury Therapeutics Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Acute Kidney Injury Therapeutics by Type 2.1 Acute Kidney Injury Therapeutics Market Segment by Type 2.1.1 Non-drug 2.1.2 Drugs 2.2 Global Acute Kidney Injury Therapeutics Market Size by Type (2017, 2022 & 2028) 2.3 Global Acute Kidney Injury Therapeutics Market Size by Type (2017-2028) 2.4 United States Acute Kidney Injury Therapeutics Market Size by Type (2017, 2022 & 2028) 2.5 United States Acute Kidney Injury Therapeutics Market Size by Type (2017-2028) 3 Acute Kidney Injury Therapeutics by Application 3.1 Acute Kidney Injury Therapeutics Market Segment by Application 3.1.1 Hospitals 3.1.2 Clinic 3.1.3 Other 3.2 Global Acute Kidney Injury Therapeutics Market Size by Application (2017, 2022 & 2028) 3.3 Global Acute Kidney Injury Therapeutics Market Size by Application (2017-2028) 3.4 United States Acute Kidney Injury Therapeutics Market Size by Application (2017, 2022 & 2028) 3.5 United States Acute Kidney Injury Therapeutics Market Size by Application (2017-2028) 4 Global Acute Kidney Injury Therapeutics Competitor Landscape by Company 4.1 Global Acute Kidney Injury Therapeutics Market Size by Company 4.1.1 Top Global Acute Kidney Injury Therapeutics Companies Ranked by Revenue (2021) 4.1.2 Global Acute Kidney Injury Therapeutics Revenue by Player (2017-2022) 4.2 Global Acute Kidney Injury Therapeutics Concentration Ratio (CR) 4.2.1 Acute Kidney Injury Therapeutics Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Acute Kidney Injury Therapeutics in 2021 4.2.3 Global Acute Kidney Injury Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Acute Kidney Injury Therapeutics Headquarters, Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) & (US$ Million) Type 4.3.1 Global Acute Kidney Injury Therapeutics Headquarters and Area Served 4.3.2 Global Acute Kidney Injury Therapeutics Companies Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Acute Kidney Injury Therapeutics Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Acute Kidney Injury Therapeutics Market Size by Company 4.5.1 Top Acute Kidney Injury Therapeutics Players in United States, Ranked by Revenue (2021) 4.5.2 United States Acute Kidney Injury Therapeutics Revenue by Players (2020, 2021 & 2022) 5 Global Acute Kidney Injury Therapeutics Market Size by Region 5.1 Global Acute Kidney Injury Therapeutics Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Acute Kidney Injury Therapeutics Market Size by Region (2017-2028) 5.2.1 Global Acute Kidney Injury Therapeutics Market Size by Region: 2017-2022 5.2.2 Global Acute Kidney Injury Therapeutics Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Acute Kidney Injury Therapeutics Market Size YoY Growth 2017-2028 6.1.2 North America Acute Kidney Injury Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 United States 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Acute Kidney Injury Therapeutics Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Acute Kidney Injury Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 China Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.3 Europe 6.3.1 Europe Acute Kidney Injury Therapeutics Market Size YoY Growth 2017-2028 6.3.2 Europe Acute Kidney Injury Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Acute Kidney Injury Therapeutics Market Size YoY Growth 2017-2028 6.4.2 Latin America Acute Kidney Injury Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Acute Kidney Injury Therapeutics Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Acute Kidney Injury Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Quark Pharmaceuticals 7.1.1 Quark Pharmaceuticals Company Details 7.1.2 Quark Pharmaceuticals Business Overview 7.1.3 Quark Pharmaceuticals Acute Kidney Injury Therapeutics Introduction 7.1.4 Quark Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) 7.1.5 Quark Pharmaceuticals Recent Development 7.2 Alloksys 7.2.1 Alloksys Company Details 7.2.2 Alloksys Business Overview 7.2.3 Alloksys Acute Kidney Injury Therapeutics Introduction 7.2.4 Alloksys Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) 7.2.5 Alloksys Recent Development 7.3 Angio Biomedica Corporation 7.3.1 Angio Biomedica Corporation Company Details 7.3.2 Angio Biomedica Corporation Business Overview 7.3.3 Angio Biomedica Corporation Acute Kidney Injury Therapeutics Introduction 7.3.4 Angio Biomedica Corporation Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) 7.3.5 Angio Biomedica Corporation Recent Development 7.4 Stealth Bio Therapeutics 7.4.1 Stealth Bio Therapeutics Company Details 7.4.2 Stealth Bio Therapeutics Business Overview 7.4.3 Stealth Bio Therapeutics Acute Kidney Injury Therapeutics Introduction 7.4.4 Stealth Bio Therapeutics Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) 7.4.5 Stealth Bio Therapeutics Recent Development 7.5 Silver Creek Pharmaceuticals 7.5.1 Silver Creek Pharmaceuticals Company Details 7.5.2 Silver Creek Pharmaceuticals Business Overview 7.5.3 Silver Creek Pharmaceuticals Acute Kidney Injury Therapeutics Introduction 7.5.4 Silver Creek Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) 7.5.5 Silver Creek Pharmaceuticals Recent Development 7.6 AM Pharma Holding 7.6.1 AM Pharma Holding Company Details 7.6.2 AM Pharma Holding Business Overview 7.6.3 AM Pharma Holding Acute Kidney Injury Therapeutics Introduction 7.6.4 AM Pharma Holding Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) 7.6.5 AM Pharma Holding Recent Development 7.7 Ischemix 7.7.1 Ischemix Company Details 7.7.2 Ischemix Business Overview 7.7.3 Ischemix Acute Kidney Injury Therapeutics Introduction 7.7.4 Ischemix Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) 7.7.5 Ischemix Recent Development 7.8 Biomerieux 7.8.1 Biomerieux Company Details 7.8.2 Biomerieux Business Overview 7.8.3 Biomerieux Acute Kidney Injury Therapeutics Introduction 7.8.4 Biomerieux Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) 7.8.5 Biomerieux Recent Development 7.9 A1M Pharma 7.9.1 A1M Pharma Company Details 7.9.2 A1M Pharma Business Overview 7.9.3 A1M Pharma Acute Kidney Injury Therapeutics Introduction 7.9.4 A1M Pharma Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) 7.9.5 A1M Pharma Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Acute Kidney Injury Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Acute Kidney Injury Therapeutics Market Trends Table 3. Acute Kidney Injury Therapeutics Market Drivers Table 4. Acute Kidney Injury Therapeutics Market Challenges Table 5. Acute Kidney Injury Therapeutics Market Restraints Table 6. Global Acute Kidney Injury Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Acute Kidney Injury Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Acute Kidney Injury Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Acute Kidney Injury Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Acute Kidney Injury Therapeutics Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Acute Kidney Injury Therapeutics Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Acute Kidney Injury Therapeutics Revenue Share by Player, 2017-2022 Table 13. Global Acute Kidney Injury Therapeutics Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Acute Kidney Injury Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Kidney Injury Therapeutics as of 2021) Table 15. Top Players of Acute Kidney Injury Therapeutics in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Acute Kidney Injury Therapeutics Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Acute Kidney Injury Therapeutics Players in United States Market, Ranking by Revenue (2021) Table 20. United States Acute Kidney Injury Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Acute Kidney Injury Therapeutics Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Acute Kidney Injury Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Acute Kidney Injury Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Acute Kidney Injury Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Acute Kidney Injury Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Acute Kidney Injury Therapeutics Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Acute Kidney Injury Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Acute Kidney Injury Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Acute Kidney Injury Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Quark Pharmaceuticals Company Details Table 31. Quark Pharmaceuticals Business Overview Table 32. Quark Pharmaceuticals Acute Kidney Injury Therapeutics Product Table 33. Quark Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) & (US$ Million) Table 34. Quark Pharmaceuticals Recent Development Table 35. Alloksys Company Details Table 36. Alloksys Business Overview Table 37. Alloksys Acute Kidney Injury Therapeutics Product Table 38. Alloksys Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) & (US$ Million) Table 39. Alloksys Recent Development Table 40. Angio Biomedica Corporation Company Details Table 41. Angio Biomedica Corporation Business Overview Table 42. Angio Biomedica Corporation Acute Kidney Injury Therapeutics Product Table 43. Angio Biomedica Corporation Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) & (US$ Million) Table 44. Angio Biomedica Corporation Recent Development Table 45. Stealth Bio Therapeutics Company Details Table 46. Stealth Bio Therapeutics Business Overview Table 47. Stealth Bio Therapeutics Acute Kidney Injury Therapeutics Product Table 48. Stealth Bio Therapeutics Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) & (US$ Million) Table 49. Stealth Bio Therapeutics Recent Development Table 50. Silver Creek Pharmaceuticals Company Details Table 51. Silver Creek Pharmaceuticals Business Overview Table 52. Silver Creek Pharmaceuticals Acute Kidney Injury Therapeutics Product Table 53. Silver Creek Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) & (US$ Million) Table 54. Silver Creek Pharmaceuticals Recent Development Table 55. AM Pharma Holding Company Details Table 56. AM Pharma Holding Business Overview Table 57. AM Pharma Holding Acute Kidney Injury Therapeutics Product Table 58. AM Pharma Holding Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) & (US$ Million) Table 59. AM Pharma Holding Recent Development Table 60. Ischemix Company Details Table 61. Ischemix Business Overview Table 62. Ischemix Acute Kidney Injury Therapeutics Product Table 63. Ischemix Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) & (US$ Million) Table 64. Ischemix Recent Development Table 65. Biomerieux Company Details Table 66. Biomerieux Business Overview Table 67. Biomerieux Acute Kidney Injury Therapeutics Product Table 68. Biomerieux Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) & (US$ Million) Table 69. Biomerieux Recent Development Table 70. A1M Pharma Company Details Table 71. A1M Pharma Business Overview Table 72. A1M Pharma Acute Kidney Injury Therapeutics Product Table 73. A1M Pharma Revenue in Acute Kidney Injury Therapeutics Business (2017-2022) & (US$ Million) Table 74. A1M Pharma Recent Development Table 75. Research Programs/Design for This Report Table 76. Key Data Information from Secondary Sources Table 77. Key Data Information from Primary Sources List of Figures Figure 1. Acute Kidney Injury Therapeutics Product Picture Figure 2. Global Acute Kidney Injury Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Acute Kidney Injury Therapeutics Market Size 2017-2028 (US$ Million) Figure 4. United States Acute Kidney Injury Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Acute Kidney Injury Therapeutics Market Size 2017-2028 (US$ Million) Figure 6. United States Acute Kidney Injury Therapeutics Market Share in Global 2017-2028 Figure 7. Acute Kidney Injury Therapeutics Report Years Considered Figure 8. Product Picture of Non-drug Figure 9. Product Picture of Drugs Figure 10. Global Acute Kidney Injury Therapeutics Market Share by Type in 2022 & 2028 Figure 11. Global Acute Kidney Injury Therapeutics Market Size by Type (2017-2028) & (US$ Million) Figure 12. Global Acute Kidney Injury Therapeutics Market Share by Type (2017-2028) Figure 13. United States Acute Kidney Injury Therapeutics Market Share by Type in 2022 & 2028 Figure 14. United States Acute Kidney Injury Therapeutics Market Size by Type (2017-2028) & (US$ Million) Figure 15. United States Acute Kidney Injury Therapeutics Market Share by Type (2017-2028) Figure 16. Product Picture of Hospitals Figure 17. Product Picture of Clinic Figure 18. Product Picture of Other Figure 19. Global Acute Kidney Injury Therapeutics Market Share by Application in 2022 & 2028 Figure 20. Global Acute Kidney Injury Therapeutics Market Size by Application (2017-2028) & (US$ Million) Figure 21. Global Acute Kidney Injury Therapeutics Market Share by Application (2017-2028) Figure 22. United States Acute Kidney Injury Therapeutics Market Share by Application in 2022 & 2028 Figure 23. United States Acute Kidney Injury Therapeutics Market Size by Application (2017-2028) & (US$ Million) Figure 24. United States Acute Kidney Injury Therapeutics Market Share by Application (2017-2028) Figure 25. North America Acute Kidney Injury Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 26. United States Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 27. Canada Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Europe Acute Kidney Injury Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. Germany Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. France Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. U.K. Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Italy Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Russia Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Acute Kidney Injury Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. China Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Japan Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. South Korea Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. India Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Australia Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. China Taiwan Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Indonesia Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Thailand Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Malaysia Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Latin America Acute Kidney Injury Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 45. Mexico Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Brazil Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Argentina Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Middle East & Africa Acute Kidney Injury Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 49. Turkey Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Saudi Arabia Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. UAE Acute Kidney Injury Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Quark Pharmaceuticals Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2017-2022) Figure 53. Alloksys Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2017-2022) Figure 54. Angio Biomedica Corporation Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2017-2022) Figure 55. Stealth Bio Therapeutics Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2017-2022) Figure 56. Silver Creek Pharmaceuticals Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2017-2022) Figure 57. AM Pharma Holding Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2017-2022) Figure 58. Ischemix Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2017-2022) Figure 59. Biomerieux Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2017-2022) Figure 60. A1M Pharma Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2017-2022) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

Quark Pharmaceuticals Alloksys Angio Biomedica Corporation Stealth Bio Therapeutics Silver Creek Pharmaceuticals AM Pharma Holding Ischemix Biomerieux A1M Pharma